Accessibility StatementSkip Navigation NEW YORK, Oct. 1, 2025 /PRNewswire/ -- The Ether Machine, Inc., a planned public company following a pending business combination with Dynamix Corporation (Nasdaq: ETHM) ("Dynamix") and The Ether Reserve LLC, announced today that it has accrued 1,350 net new ether (ETH) as yield (currently valued at approximately $5.6M) through its actively managed ETH staking strategy. These rewards were generated at some of the lowest costs in the industry due to the Ether Machine's ...

Core Insights - Phoenix Motor Inc. is expanding its digital payment options to include Ethereum (ETH), BNB, and Solana (SOL) in addition to Bitcoin [1] - The company is implementing a comprehensive crypto treasury management plan to securely manage and optimize its digital asset holdings [1]

Core Viewpoint - RYVYL Inc. is repositioning its business to focus on crypto treasury management, with a core strategy aimed at building a crypto treasury to support long-term growth [1][2]. Company Leadership Changes - Ben Errez, Chairman and Co-founder of RYVYL, will retire effective August 31, 2025, but will continue to advise the company independently through the end of the year [1][2]. Strategic Business Shift - The company announced a digital asset acquisition strategy on June 16, 2025, planning to accumulate crypto as a reserve asset, viewing it as a long-term store of value and a means to enhance financial resilience [2][3]. - The decision to shift the business reflects a long-term approach to integrating digital assets into the treasury, aiming to enhance balance sheet strength and position the company for future financial innovation [3]. Company Background - RYVYL Inc. was founded in 2017 as GreenBox POS and focuses on empowering various payment transactions globally through electronic payment technology [3]. - The company has developed applications that provide an end-to-end suite of financial products with enhanced security, data privacy, and rapid settlement speed [3].

Core Viewpoint - Jeffs' Brands Ltd is implementing an AI-driven crypto treasury management program to optimize yields from leading cryptocurrencies, including Bitcoin and stable coins [1][2]. Group 1: Treasury Program Overview - The Treasury Program will be managed by Quantum Crypto, an affiliate of Tectona Ltd, which holds a 41% stake in Horizon, a prominent Israeli crypto trading platform [1][3]. - The Company plans to allocate up to $75 million from a private placement of convertible promissory notes for the Treasury Program, contingent on the successful setup of crypto wallets [2]. Group 2: Agreement Details - An agreement was established on August 4, 2025, between Jeffs' Brands and Quantum Crypto for crypto treasury management services, including infrastructure and trading services [4]. - Jeffs' Brands will retain full ownership of its digital assets and private keys, with Quantum Crypto ensuring compliance with regulatory requirements [4]. Group 3: Compensation Structure - Quantum Crypto will receive a one-time setup fee of $25,000, a monthly fee of 0.125% of the average daily balance of managed crypto assets, and a performance-based fee of 20% of gross revenues from staking [5]. - The Company will also issue a warrant to Quantum Crypto for the purchase of up to 27,619 ordinary shares at an exercise price of $0.01 per share, representing approximately 4.99% of the currently outstanding shares [5]. Group 4: Company Background - Jeffs' Brands aims to transform e-commerce by creating and acquiring products to become market leaders, leveraging both human capability and advanced technology [6].

Core Viewpoint - Sonnet BioTherapeutics, Inc. is entering a business combination with Rorschach I LLC to create Hyperliquid Strategies Inc, which will hold a significant reserve of HYPE tokens, positioning it as a leading cryptocurrency treasury management company in the U.S. [1][2][5] Company Overview - Sonnet BioTherapeutics is an oncology-focused biotechnology company utilizing a proprietary platform for developing biologic drugs, specifically targeting tumor and lymphatic tissues [13]. - The company is known for its Fully Human Albumin Binding (FHAB) technology, which enhances the safety and efficacy of immune-modulating biologic drugs [13]. Business Combination Details - The business combination will result in Hyperliquid Strategies Inc (HSI) holding approximately 12.6 million HYPE tokens valued at $583 million and gross cash proceeds of at least $305 million, leading to a total assumed closing value of $888 million [2][3]. - Prominent strategic investors participating in the transaction include Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital [2]. Management and Governance - Upon closing, Bob Diamond will serve as Chairman of the Board, and David Schamis will be the Chief Executive Officer of HSI, with plans to appoint a new Chief Financial Officer and additional board members [3][5]. Financial Strategy - The gross cash proceeds from the business combination will enable HSI to acquire more HYPE tokens, establishing one of the top strategic reserves of the token [3]. - Sonnet will also raise $5.5 million through a private placement to accredited investors, which will support general corporate purposes and the development of its biotech assets [6]. Future Operations - Post-combination, Sonnet will operate as a wholly owned subsidiary of HSI, continuing its focus on existing biotech assets while potentially disposing of others [7]. - Current owners of Rorschach and new investors are expected to own approximately 98.8% of HSI, while legacy stockholders of Sonnet will hold about 1.2% [8]. Regulatory and Approval Process - The business combination has been approved by the governing boards of both companies and is subject to Sonnet stockholder approval and customary closing conditions, with an expected closing in the second half of the year [9].